Clin Oncol, 33 (2015), pp. 3650-3659 (4)J.M. Ostrem, K.M. Shokat;Direct small-molecule inhibitors
of a ubiquitin ligase, lead to protein degradation1. Unlike traditional enzyme inhibitors
is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors
–neprilysin inhibitors [ARNIs], and sodium/glucose cotransporter 2 [SGLT2] inhibitors)(HFrEF
2019; 12:10343–10360.11. Pasquini G, Giaccone G. C-MET inhibitors for advanced non-small cell lung